Kayexalate - Food and Drug Administration
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/011287s022lbl.pdf
WEBKAYEXALATE is indicated for the treatment of hyperkalemia. CONTRAINDICATIONS . KAYEXALATE is contraindicated in the following conditions: patients with hypokalemia, patients with a history of hypersensitivity to polystyrene sulfonate resins, obstructive bowel disease, neonates with reduced gut motility (postoperatively or drug induced) and oral
DA: 48 PA: 26 MOZ Rank: 83